Considerations for Biosafety Testing of Cell and Gene Therapies

被引：0
|
作者：
Adair, Richard [1 ]
机构：
[1] SGS Vitrol Ltd, Virol, Clydebank, Scotland
来源：
MOLECULAR THERAPY | 2019年 / 27卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
202
引用
收藏
页码：103 / 103
页数：1
相关论文
共 50 条
  • [21] B cell targeted therapies: Safety considerations
    Kavanaugh, Arthur F.
    JOURNAL OF RHEUMATOLOGY, 2006, 33 : 18 - 23
  • [22] Regulatory Considerations in Application of Encapsulated Cell Therapies
    van Zanten, J.
    de Vos, Paul
    THERAPEUTIC APPLICATIONS OF CELL MICROENCAPSULATION, 2010, 670 : 31 - 37
  • [23] Regulatory considerations for pluripotent stem cell therapies
    Carpenter, Melissa K.
    FUNCTIONAL NEURAL TRANSPLANTATION IV: TRANSLATION TO CLINICAL APPLICATION, PT A, 2017, 230 : 151 - 163
  • [24] Development of COVID-19 therapies: Nonclinical testing considerations
    Baldrick, Paul
    REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2022, 132
  • [25] General Considerations on the Biosafety of Virus-derived Vectors Used in Gene Therapy and Vaccination
    Baldo, Aline
    van den Akker, Eric
    Bergmans, Hans E.
    Lim, Filip
    Pauwels, Katia
    CURRENT GENE THERAPY, 2013, 13 (06) : 385 - 394
  • [26] Industrializing cell and gene therapies
    Shanley, Agnes
    Pharmaceutical Technology, 2019, 2019 (04)
  • [27] The Rise of Cell and Gene Therapies
    Hilas, Olga
    US PHARMACIST, 2024, 49 (10)
  • [28] TRANSLATION OF CELL AND GENE THERAPIES
    Narayanan, G.
    CYTOTHERAPY, 2016, 18 (06) : S23 - S23
  • [29] Gene and cell therapies in demand
    King, Anthony
    CHEMISTRY & INDUSTRY, 2019, 83 (05) : 8 - 8
  • [30] Gene and stem cell therapies
    Kaji, EH
    Leiden, JM
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (05): : 545 - 550
12345